CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bermele PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bermele PLC
6th Fl
Allianz House, 60 Gracechurch Street
Phone: +44 2034759760p:+44 2034759760 LONDON, EC3V 0HR  United Kingdom Ticker: BERMBERM

Business Summary
Bermele PLC is a United Kingdom-based special purpose acquisition company. The Company is formed for the purpose of acquiring a business or businesses operating in the pharmaceutical and biotechnology sectors. Its focus areas include diabetes, cancer, mental health and personalized medicine.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
7/31/20191/31/2019Yes----

Industries
SIC Code Description
6726 Unit investment trusts, face-amount certificate offices

General Information
Number of Employees: 1 (As of 1/31/2019)
Outstanding Shares: 200,000,000 (As of 7/31/2019)
Stock Exchange: LON


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 14, 2019